I am a breastfeeding mother and i want to know if it is safe to use Ultratrace iobenguane I131? Is Ultratrace iobenguane I131 safe for nursing mother and child? Does Ultratrace iobenguane I131 extracts into breast milk? Does Ultratrace iobenguane I131 has any long term or short term side effects on infants? Can Ultratrace iobenguane I131 influence milk supply or can Ultratrace iobenguane I131 decrease milk supply in lactating mothers?
Information in this record refers to the use of Ultratrace iobenguane I131 (I 131 meta-iodobenzylguanidine; I 131 MIBG) as a diagnostic agent. The International Commission on Radiological Protection states that breastfeeding should be interrupted for more than 3 weeks following diagnostic use of I 131 MIBG. After therapeutic dosages, the manufacturer recommends that breastfeeding should be withheld for 80 days after the final dose. These times usually result in permanent discontinuation of breastfeeding for this infant, and cessation of breastfeeding for the current infant is recommended by most experts.[1][2] Patients receiving Ultratrace iobenguane I131usually receive potassium iodide prior to the diagnostic examination to block their thyroid gland's uptake of the I-131 that is released from the I 131 MIBG. Iodide may interfere with the infant's thyroid function. Nursing mothers should not work with substances containing I 131 in their workplace.[3]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.